Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-20-000019

Chief Scientific Officer gave up 3,246 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Calias Pericles · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-07-16 Shares withheld for taxes : show line 1 in the form −3,246 $4.90 $15,905 49,216 D
Loading xslF345X03/primary_doc.xml…